Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
1 drug for “Neurofibromatosis 1”
Approved 1
- SelumetinibASTRAZENECA PLCNeurofibromatosis 1
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.